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Abstract
Background: Evidence suggests that a substantial proportion of new HIV infections in African
countries are associated with herpes simplex virus type 2 (HSV-2). Thus, the magnitude of HSV-2
infection in an area may suggest the expected course of the HIV epidemic. We determined
prevalence of genital herpes, syphilis and associated factors among pregnant women from a remote
rural Tanzanian community that has a low but increasing HIV prevalence.
Methods: We analysed 1296 sera and responses to a standard structured questionnaire collected
from pregnant women aged between 15–49 years, attending six different antenatal clinics within
rural Manyara and Singida regions in Tanzania. Linked anonymous testing (with informed consent)
of the serum for specific antibodies against HSV-2 was done using a non-commercial peptide- 55
ELISA. Antibodies against syphilis were screened by using rapid plasma reagin (RPR) and reactive
samples confirmed by Treponema pallidum haemagglutination assay (TPHA).
Results: Previous analysis of the collected sera had shown the prevalence of HIV antibodies to be
2%. In the present study the prevalence of genital herpes and syphilis was 20.7% (95% CI: 18.53–
23.00) and 1.6% (95% CI: 1.03–2.51), respectively. The presence of HSV-2 antibodies was
associated with polygamy (OR 2.2, 95% CI: 1.62 – 3.01) and the use of contraceptives other than
condoms (OR 1.7, 95% CI: 1.21 – 2.41). Syphilis was associated with reporting more than one
lifetime sexual partner (OR 5.4, 95% CI: 1.88 – 15.76) and previous spontaneous abortion (OR 4.3,
95% CI: 1.52–12.02).
Conclusion: The low prevalence of HIV infection offers a unique opportunity for strengthening
HIV prevention in a cost-effective manner. The identification and control of other prevalent curable
STIs other than syphilis and specific intervention of HSV-2 in specific populations like pregnant
women would be one among approaches towards preventing incident HIV infections.
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There is strong evidence that a substantial proportion of
new HIV infections in African countries are associated
with herpes simplex virus type 2 (HSV-2) [1-6]. Infection
with HSV-2 has a significant impact on the risk of HIV
acquisition and the impact increases as the HIV epidemic
progresses [7,8]. One reason for this association could be
the relative importance of HSV-2 in genital ulcer disease
(GUD) in Africa has increased markedly. Infection with
HSV-2 disrupts the genital mucosa and provides a portal
of entry for HIV, leading to increased susceptibility of HIV
in HIV-negative persons. In HIV-positive persons, infec-
tion with HSV-2 accelerates replication and genital shed-
ding of the virus, thus such individuals are more likely to
transmit HIV [9]. Studies from sub-Saharan countries
have reported a high prevalence of HSV-2 in adults rang-
ing from 30% to 80% in women and up to 50% in men
[5,10,11]. In Tanzania, recent studies have shown HSV-2
represents 71% to 83% of all identified pathogens in gen-
ital ulcers [12,13]. Thus, the magnitude of HSV-2 infec-
tion may suggest the expected course of the HIV epidemic.
Tanzania is among the countries with a stabilised HIV epi-
demic. The estimated adult HIV prevalence was 8% by the
end of 2004 based on data from the Tanzania HIV/AIDS
indicator survey [14], closely matching HIV estimates
(8.7%) reported from antenatal clinic surveillance in the
same year [15]. The HIV prevalence (2%) in Manyara
region by the end of 2004, matched with the estimate
pregnant women attending local clinics within rural Man-
yara and Singida regions [14,16]. In the antenatal group,
young women (15–19 years) presented with the highest
prevalence (3.0%) and in the general population, men
aged 35–49 years [16,17]. In comparison with other
regions in Tanzania, the HIV prevalence is still low [14].
The magnitude of HSV-2 in the same area is largely
unknown, while the prevalence of syphilis among preg-
nant women was 17% as reported by a previous study
within the area [18]. Unlike genital herpes, studies explor-
ing syphilis as a GUD enhancing HIV susceptibility and
infectiousness in high-risk groups have revealed conflict-
ing results [19,20]. The limitations have been due to
either a few number of syphilis cases or case ascertain-
ment by self-reports rather than laboratory confirmed
results. In Tanzania, 51% of all stillbirths are associated
with maternal syphilis [21]. Analysis of maternal syphilis
and HIV prevalence among pregnant women attending
selected antenatal clinics in by the end of 2004 showed
geographical variation in the prevalence [22]. Rural ante-
natal clinics had high prevalence of syphilis (9.5%) and
low HIV prevalence (5.2%) compared with other sites
(6.8% syphilis vs. 9.3% for HIV). The high prevalence was
associated with lack of formal education, inadequate
access to health care and poverty [23,24]. Thus to deter-
mine the prevalence of syphilis and genital herpes in this
rural area with low but increasing HIV prevalence, we ana-
lysed antibodies against HSV-2 and Treponema pallidum.
We used data and serum samples collected from a previ-
ously reported antenatal survey [16].
Methods
Study area and population
The current study was part of the epidemiological study
conducted within the remote rural areas of Manyara and
Singida in Tanzania. The area falls within the service
catchment area of Haydom Lutheran Hospital (HLH). The
main focus aimed towards understanding the epidemio-
logical context of HIV in the area as part of the compre-
hensive prevention-intervention programme launched by
the hospital to combat HIV and other sexually transmitted
infections in the area [25]. Part of the interventions
included voluntary counselling and testing for HIV (VCT),
syphilis and HSV-2. Education provided for participants
included HIV- related preventive education and benefits
of highly active antiretroviral treatment (HAART) for pre-
vention of mother to child transmission (PMTCT)
explained, according to national guidelines for care and
treatment of people living with HIV and AIDS.
Sampling
The survey included six antenatal clinics within the three
administrative divisions that comprised the above-
defined catchment area, between November 2003 and
April 2004, and the study population is described in detail
[16]. In brief, it included all counselled and consenting
pregnant women aged between 15–49 years attending six
local antenatal clinics (ANC) for the first time in that par-
ticular pregnancy during the surveillance period. Two
clinics from each administrative division were included.
Based on previous estimates of HIV, HSV-2 and syphilis
prevalence in the area, HIV prevalence was the lowest, so
the sample size was based on that estimate. A sample size
of 1000 pregnant women would allow us to calculate a
2% prevalence of HIV with 95% confidence intervals of 1
to 3%. Point prevalence estimates of HIV, HSV-2 and
syphilis are presented as the point estimate with their 95%
confidence intervals.
Data collection tools and laboratory methods
The research team collaborated with the hospital PMTCT
teams in data collection. The PMTCT team was responsi-
ble for registration and coding of participant's identities
and providing follow up care. The research team used a
standard structured questionnaire to obtain information
regarding socio-demographic and sexual behaviour char-
acteristics. Included in the questionnaires were marital
status, self-reported history of sexually transmitted infec-
tions and genital ulcers, the use of condoms and other
contraceptives, and sexual partners. Blood was collected
using vacutainers, and prepared serum samples werePage 2 of 8
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and syphilis the next day. Following HIV and syphilis
antibody testing, the samples were stored at -80°C until
analysis for HSV-2 antibodies. Screening for anti-HIV IgG
antibody was performed anonymously using Bionor HIV-
1 & 2 assay® (BIONOR AS, Skien, Norway). Reactive sam-
ples were confirmed using Bionor HIV-1 & 2 assay®
(BIONOR AS, Skien, Norway). Screening for syphilis was
done using Rapid plasma reagin (RPR) by Omega Immu-
trep-RPR®, Omega Diagnostics, Alva, UK and the reactive
samples were confirmed by TPHA (Immutrep TPHA®,
Omega Diagnostics, Alva, UK). Positive RPR and TPHA
tests were considered to indicate current or untreated
syphilis. Specific antibodies for HSV-2 were detected by
the non-commercial peptide-55 Enzyme-linked immuno-
sorbent assay as described elsewhere [26-28]. The assay is
specific for reactivity with an epitop within glycoprotein G
of HSV-2 (gG2) and does not cross-react with Herpes sim-
plex virus type 1. Sensitivity and specificity of 100% and
98.4%, respectively, have been reported [27].
The cut-off value was set at a mean absorbance of the neg-
ative controls plus five standard deviations. Tanzanian
sera, initially analysed by the same assay and the results
confirmed with a commercial HerpeSelect 1 and 2 Immu-
noblot IgG ® (IB0900G) from Focus Technologies Inc.
(USA), were used as positive and negative controls [29].
The Regional Committee for Medical, Health Research,
and Ethics in Western Norway (REK) and the Tanzanian
National Institute of Medical Research (NIMR) gave ethi-
cal approval for research exploring HIV, HSV-2 and syph-
ilis within the mentioned area. Regional and District level
Ethical approval was sought and granted. Oral informed
consent was sought from individuals and they where
informed of their right to refuse to participate with out
any consequences.
Statistical analyses
Data were entered twice in Excel spreadsheets and ana-
lysed using Stata 9.2® (College station, Texas, USA). We
assessed self-reported previous adverse pregnancy out-
comes as a probable indicator of previous syphilitic infec-
tion for women with previous pregnancies. The age at first
pregnancy was explored as an indirect measure of unpro-
tected sexual intercourse. The prevalence of HSV-2 and
syphilis was compared to the previously reported HIV
prevalence in the same population of pregnant women to
assess the coexistence of these infections. We define polyg-
amous relationship as women with sexual relations with
a man having more than one wife or sexual partner(s) at
the same time and monogamous relation women in mar-
riage or sexual relationship with a man who has no other
but only one wife/sexual partner at the same time.
Logistic regression was used to explore potential risk fac-
tors for HSV-2 and syphilis. Since HSV2 antibodies
remain for life in infected people, older pregnant women
would be more likely to have antibodies from previously
acquired HSV2 infections. We adjusted for age in the anal-
ysis of HSV-2 and risk factors to avoid overestimation in
older women and underestimation in younger women
thus allowing comparison of the risk of HSV-2 infection.
Variables with p-values less than 0.25 on age-adjusted
analysis were included in the final multivariate model and
the associations presented as Odds ratios (OR) with a
95% confidence interval (CI).
Results
In a sample of 1377 consenting pregnant women, 1296
women completed interviews and provided serum sam-
ples for laboratory testing. Four per cent of women (58/
1377) declined a blood test, and we discarded 1.7% (23/
1319) haemolysed samples. The mean age of the studied
population was 26.3 (SD ± 6.1) years and the mean age at
first pregnancy was 19 (SD ± 3) years. Ninety-one per cent
of the women were married (Table 1) and 79% of them
reported monogamous marriage while 28% of all women
had no formal education.
Table 1 summarizes results on HSV-2 prevalence and
associated factors. The overall prevalence of HSV-2 was
20.7% (95% CI: 18.53–23.00), varying between 7.0% and
32.9%. HSV-2 prevalence increased with age, ranging
from 19% in the 15–19 year age group to 27% among
women aged 35 years or older. The prevalence was
between 18% and 35% for all socio-demographic varia-
bles. Women in polygamous relationships, had high prev-
alence of HSV-2 (32.7%, 95% CI: 27.24–38.69)
compared with women in monogamous relationships
(17%, 95% CI: 15.23–19.90). HSV-2 prevalence did not
differ with a history of condom use and only 4.9% of the
women reported to have ever used condoms.
In age-adjusted analysis, the likelihood of HSV-2 antibod-
ies was associated with a self-reported history of sexually
transmitted infections, polygamous relationship, using
non-condom contraceptives and more than one lifetime
sexual partner. On multivariate analysis, all clinics except
Basotu had high odds ratios of HSV-2 infection. Higher
odds were particularly seen in Muslur (OR 6.8 (95% CI:
3.76–12.27) and Dangayda clinics (OR 5.3 (95% CI: 2.78
– 10.16), Table 1 right column. HSV-2 remained signifi-
cantly associated with polygamous relationships, OR 2.2
(95% CI: 1.62 – 2.99) or the use of non-condom contra-
ceptives OR 1.7 (95% CI: 1.21–2.41) and weakly associ-
ated with more than one lifetime sexual partner (OR 1.8
(95% CI: 1.04–3.04). We found no dual infections with
HIV for those with HSV-2 antibodies (data not shown).Page 3 of 8
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Table 1: The prevalence of genital herpes and associated factors among pregnant women
Characteristics N (%) HSV-2 prevalence % 
(95% CI)
Age-adjusted OR (95% CI) Multivariate analysis OR 
(95% CI)
Total 1296 20.7 (18.53–23.00)
Clinic
Basotu 242 (18.7) 7.0 (4.27 – 11.21) 1 1
Haydom 319 (24.6) 23.8 (19.33 – 28.86) 4.2 (2.41 – 7.31) * 4.2 (2.39 – 7.41) *
Muslur 192 (14.8) 32.8 (26.32 – 40.00) 6.5 (3.63 – 11.52) * 6.8 (3.76 – 12.27) *
Dangayda 113 (8.7) 32.9 (23.59 – 41.38) 6.0 (3.19 – 11.35) * 5.3 (2.78 – 10.16) *
Mwanga 249 (19.2) 20.1 (15.40 – 25.71) 3.3 (1.86 – 5.95) * 3.3 (1.84 – 6.02) *
Nduguti 181 (14.0) 14.4 (9.76 – 20.53) 2.2 (1.16 – 4.23) * 2.2 (1.15 – 4.24) *
Age groups (years)
15–19 165 (12.7) 19.5 (13.91 – 26.58) 1
20–24 417 (32.2) 19.4 (15.80 – 23.62) 1.0 (0.63 – 1.57) 0.8 (0.48 – 1.28)
25–29 349 (26.9) 17.4 (13.69 – 21.90) 0.9 (0.54 – 1.40) 0.7 (0.41 – 1.13)
30–34 224 (17.3) 24.5 (19.58 – 31.30) 1.3 (0.82 – 2.19) 0.9 (0.55 – 1.61)
≥35 141 (10.9) 27.7 (20.62 – 35.93) 1.6 (0.92 – 2.69) 1.0 (0.56 – 1.77)
Marital status
Married 1183 (91.3) 20.9 (18.62 – 23.33) 1 __
Single/divorced/separated/
widow
113(8.7) 18.6 (12.12 – 27.23) 1.1 (0.68 – 1.91)
Education (years)
None 349 (28.2) 20.9 (16.85 – 25.64) 1 __
1–6 years 174 (13.4) 17.8 (12.60 – 24.49) 0.8 (0.51 – 1.40)
7 years or more 773 (59.7) 21.2 (18.42 – 24.30) 1.0 (0.74 – 1.9)
a Polygamous relationship
No 1024 (79.0) 17.5 (15.23–19.90) 1
Yes 272 (21.0) 32.7 (27.24–38.69) 2.2 (1.63 – 3.01) * 2.2 (1.62 – 2.99) *
b Age at first pregnancy
< 18 years 158 (14.0) 23.4 (17.21 – 30.94) 1
≥ 18 years 974 (86.0) 20.4 (17.97 – 23.13) 1.2 (0.85–1.73) 1.2 (0.82 – 1.70)
Number of lifetime sexual 
partners
One only 1231 (95.0) 18.2 (16.14 – 20.54) 1
More than one 65 (5.0) 35.3 (24.36 – 47.90) 2.0 (1.21 – 3.46) * 1.8 (1.04 – 3.04)
Use of contraceptives other 
than condom
No 1088 (84.0) 19.2 (16.93–21.71) 1 1
Yes 208 (16.0) 28.4 (22.45–35.09) 1.7 (1.20–2.37)* 1.7 (1.21–2.41) *
History of sexually 
transmitted infections
No 1135 (87.6) 19.8 (17.56 – 22.29) 1
Yes 161 (12.4) 27.0 (20.20 – 34.35) 1.5 (1.01 – 2.17) 1.3 (0.87–1.92)
Ever used condom
No 1233 (95.1) 20.6(18.47 – 23.07) 1 __
Yes 63 (4.9) 20.6 (11.85 – 33.04) 1.1 (0.56 – 1.97)
aRelationship with a man having more than one female sexual partner regardless of marital status
b Analysed for those aged 20 ≥ years at the time of survey
Total HSV-2 positive (n = 268/1296)
*P-values: < 0.01
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risk of HSV-2 antibodies (Table 1).
The overall prevalence of syphilis was 1.6%, but was
higher in women aged 20–24 years and 30–34 years
(2.4% and 3.1%) (Table 2). The highest prevalence of
syphilis (8.8%) was associated with more than one life-
time sexual partner, followed by self-reported spontane-
ous abortion 6.1%. Women in polygamous relationships
and those with a self-reported history of sexually transmit-
ted infection had a prevalence of 3.7% (95% CI: 1.88–
6.87) and 3.1% (95% CI: 1.15–7.48), respectively. None
of those who had ever used condoms had antibodies
against syphilis. Prevalence of syphilis in women aged less
than 18 at first pregnancy was 2.5% (Table 2) and 1.7%
for pregnancies at older age.
In multivariate analysis, women who reported previous
spontaneous abortion as an adverse pregnancy outcome,
were more likely to have a positive syphilis serology (OR
4.3, 95% CI: 1.52–12.02) compared with those reporting
stillbirth (OR 2.4, 95% CI: 0.64–8.95). Odds were also
higher for women who had more than one lifetime sexual
partner, OR 5.4 (95% CI: 1.88–15.76). Dual syphilis and
HIV infection occurred in only one individual aged 30
years and this person had had more than one lifetime sex-
ual partner. Eight of the 21 women with syphilis were
infected with HSV-2 (OR 2.5, 95% CI: 0.32 – 19.36), but
the figures are too small to interpret the precise associa-
tion. In addition, being less than 18 years at first preg-
nancy did not have a significantly increased risk of
positive syphilis serology.
Discussion
The overall prevalence of HSV-2 antibodies among preg-
nant women in the rural Manyara and Singida regions in
Tanzania was 20.7%, varying from 7% to 33% between
clinics and increasing with age. This is a slightly lower
prevalence than observed by Obasi and colleagues in a
different rural region in Tanzania (Mwanza) where 42%
of the women had HSV-2 antibodies [30]. The prevalence
of syphilis in the present study (1.6%) is much lower than
previously observed (17%) in this region, the finding may
partly reflect the effect of syndromic management of STI
imposed in health services since 1999 [31]. Our findings
though suggestive of the relatively low HSV-2 and syphilis
prevalence in the area compared to other places in Tanza-
nia, point out a potential opportunity for indirect HIV
prevention by controlling prevalent STIs.
Measurement of the HSV-2 antibodies was performed
with a non-commercial method using a branched peptide
with a sequence similar to a specific epitope in glycopro-
tein G of HSV-2 [26,28]. Commercial assays use the entire
glycoprotein G, and may sometimes have problems with
false positive results. When comparing performance of
peptide 55 method with Western blot, we did not detect
any false positive results in Tanzanian sera from persons
13 years old or older [32].
Studies from rural areas in Gambia in West Africa, using
the peptide 55 method, have shown infection in 30% of
the studied women [33,34]. Other prevalence studies in
urban regions of Tanzania have shown that 35% of preg-
nant women in Dar es Salaam [35] and 39% of women
attending primary health care clinics in Moshi were
infected with HSV-2 [4]. Among STD patients in urban
Mbeya and Dar es Salaam regions of Tanzania, HSV-2 was
the most commonly (71%) identified agent in genital
ulcer specimens [12]. In these patients, detection of HSV-
2 was at significantly higher in HIV infected compared to
those not infected [12]. Therefore, taken together, these
results indicate a generalised HSV-2 infection in the Tan-
zanian population. Suggestions on the limited impact of
HSV-2 on incident HIV infections in the early stages of the
HIV epidemic may also hold true for this area [7]. Despite
the generalised, stable HIV epidemic in Tanzania, the epi-
demiological patterns of STIs have shown regional varia-
tions on the level and magnitude, largely influenced by
cultural, economical political and social factors. [14,17].
The prevalence of HSV-2 was significantly higher in all
clinics compared to Basotu clinic but this village report-
edly, had the highest HIV prevalence [17]. We are uncer-
tain to the reasons that might explain this distribution.
Basotu presents a very mixed population compared to the
other villages, Lake Basotu may attract fishermen from
other regions and in-migration of HIV infected persons is
possible. Fishing provides a substantial economical gain
that is lacking in other villages.
Our definition of positive syphilis serology would not
only include those with infectious syphilis (primary and
secondary), but also cases of untreated latent syphilis
though persons in the latent syphilitic state are non-infec-
tious. Reported estimates of the prevalence of syphilis in
other rural antenatal sentinel sites in Tanzania in 2004
ranged from 14.9% in Kagera and 2.1% in Kigoma region.
The corresponding prevalence of HIV was 4.7% and 5.1%
respectively [15]. The later study performed RPR under
field conditions, and lacked confirmatory tests for syphilis
and likely to have overestimated prevalence of syphilis.
Likewise, Kagera region is experiencing a different stage of
the HIV epidemic compared to rural Manyara, Singida
and Kigoma regions. Kagera was the first region in Tanza-
nia to report AIDS cases and experienced a severe HIV epi-
demic (24.2%) since 1987 and is low levelling off as a
result of excessive mortality and multiple interventions
[36]. While rural Manyara, Singida and Kigoma regions
had relatively lower HIV prevalence in the last decade but
have recently shown an increasing potential. Thus, thePage 5 of 8
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Manyara and Singida region is with caution. The propor-
tion of active syphilis in our study might be lower than
our prevalence estimates by using TPHA, since antibodies
detected by this method remain for life. While, the use of
Venereal Disease Research Laboratory (VDRL) test alone
in the previous local study in 1999 might have overesti-
mated the prevalence [18].
The low prevalence of HIV in our study (2.0%) may
explain why we did not detect an association between
infections with HIV and HSV-2. The potential reason for
the low prevalence was associated with remoteness and
reduced mobility of the people within this rural area.
High numbers of lifetime sexual partners have previously
shown to increase the risk of acquiring infection with
HSV-2 and syphilis [4,35,37]. These risk factors are also
Table 2: The prevalence of syphilis and associated factors among pregnant women
Characteristics N (%) Syphilis prevalence % 
(95% CI)
Age-adjusted OR (95% CI) 
(p-value)
Multivariate analysis OR 
(95% CI) (p-value)
Total 1296 1.6 (1.03 – 2.51)
Age groups (years)
15–19 165 (12.7) 0 __ __
20–24 417 (32.2) 2.4 (1.22 – 4.51)
25–29 349 (26.9) 0.9 (0.22 – 2.69)
30–34 224 (17.3) 3.1 (1.38 – 6.60)
≥35 141 (10.9) 0.7 (0.03 – 4.47)
Marital status
Married 1183 (91.3) 1.8 (1.13 – 2.75)
Single/divorced/separated/widow 113 (8.7) 0 __ __
Education (years)
None 349 (28.2) 2.3 (1.07 – 4.64) 1
1–6 years 174 (13.4) 1.7 (0.45 – 5.36) 0.8 (0.20 – 2.85)
7 years or more 773 (59.7) 1.3 (0.66 – 2.48) 0.6 (0.22 – 1.43) __
Polygamous relationship
No 1024 (79.0) 1.1 (0.57 – 1.98) 1 1
Yes 272 (21.0) 3.7 (1.88 – 6.87) 2.7 (1.08 – 6.64) (p = 0.03) 2.6 (1.06 – 6.51) (p = 0.03)
a Age at first pregnancy
< 18 years 158 (14.0) 2.5 (0.81 – 6.76) __
≥ 18 years 974 (86.0) 1.7 (1.05 – 2.84)
Outcome of previous pregnancy (n 
= 1155)
Live child 916 (79.3) 1.3 (0.71 – 2.34) 1 1
Stillbirth 140 (12.1) 2.1 (0.55 – 6.62) 1.6 (0.45 – 5.92) 2.4 (0.64 – 8.95)
Spontaneous abortion 99 (8.57) 6.1 (2.49 – 13.24) 4.9 (1.78 – 13.25) (p = 0.00) 4.3 (1.52 – 12.02) (p = 0.00)
Number of lifetime sexual 
partners
One only 1231 (95.0) 1.2 (0.71 – 2.05) 1 1
More than one 65 (5.0) 8.8 (3.64 – 18.85) 7.8 (2.94 – 20.86) (p = 0.00) 5.4 (1.88 – 15.76) (p = 0.00)
Use of contraceptives other than 
condom
No 1088 (84.0) 1.8 (1.16 – 2.88) 1 1
Yes 208 (16.0) 0.5 (0.02 – 3.06) 0.3(0.03 – 1.93) 0.3 (0.04 – 2.66)
History of sexually transmitted 
infections
No 1135 (87.6) 1.4 (0.84 – 2.33) 1 1
Yes 161 (12.4) 3.1 (1.15 – 7.48) 2.2 (0.81 – 6.20) 1.8 (0.60 – 5.18)
Ever used condom
No 1233 (95.1) 1.7 (1.08 – 2.64) __ __
Yes 63 (4.9) 0
Total syphilis positive (n = 21/1296). Results for analysis of syphilis prevalence by clinic locations are not shown due to very small numbers or none-to give any substantial 
statistical inference.
a Analysed for those aged 20 ≥ years at the time of survey (n = 1132)Page 6 of 8
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Women in polygamous relationships presented with
higher prevalence of HSV-2 (Table 2), in agreement with
a report from Gambia [11]. In the present work as well as
in others syphilis was shown to be a high probable risk for
spontaneous abortion (Table 2) [38,39]. However, we did
not find an association with stillbirth, even though 25%
of the pregnancies might result in stillbirth in cases of
maternal syphilis [21]. The lack of association in our study
could be, partly due to confounding effects of other causes
of stillbirth, beyond the scope of this study and the lower
number of syphilis cases. Although sexual transmission of
syphilis is usually limited to the early stages, vertical trans-
mission is still possible in latency.
Conclusion
Though we cannot rule out the effect of other STIs on the
level HIV infection presented, the identified risk factors
for STI are similar to other areas in Tanzania that have
experienced a higher level of HIV and related STIs. The
low but changing prevalence of HIV infection offers a
unique opportunity for strengthening HIV prevention in a
cost-effective manner [40]. The identification and control
of other prevalent curable STIs other than syphilis and
specific intervention for HSV-2 in specific populations
like pregnant women should be among approaches
towards preventing incident HIV infections.
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